Invex Therapeutics Ltd
ASX:IXC
Balance Sheet
Balance Sheet Decomposition
Invex Therapeutics Ltd
Invex Therapeutics Ltd
Balance Sheet
Invex Therapeutics Ltd
| Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
12
|
26
|
33
|
29
|
22
|
6
|
5
|
|
| Cash |
12
|
26
|
33
|
29
|
22
|
6
|
5
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
12
|
26
|
33
|
29
|
23
|
6
|
5
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
12
N/A
|
26
+113%
|
33
+24%
|
29
-10%
|
23
-23%
|
6
-73%
|
5
-11%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Accrued Liabilities |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
2
|
1
|
1
|
2
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
2
+115%
|
1
-67%
|
1
+52%
|
2
+57%
|
0
-73%
|
0
-49%
|
|
| Equity | ||||||||
| Common Stock |
12
|
27
|
36
|
36
|
36
|
22
|
22
|
|
| Retained Earnings |
0
|
3
|
4
|
8
|
15
|
17
|
17
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
11
N/A
|
24
+113%
|
32
+31%
|
28
-11%
|
21
-25%
|
6
-73%
|
5
-8%
|
|
| Total Liabilities & Equity |
12
N/A
|
26
+113%
|
33
+24%
|
29
-10%
|
23
-23%
|
6
-73%
|
5
-11%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
55
|
68
|
75
|
75
|
75
|
75
|
75
|
|